Doctors in Shanghai have screened two protein markers to determine pancreatic cancer patients' sensitivity to chemotherapy, which may rewrite current treatment guidelines and improve patients' overall survival rate.
The team of researchers from Shanghai Ruijin Hospital said on Monday that the results of the study have been validated in three groups at home and abroad, showing strong clinical applicability.
A paper about the study was published as the cover article in the top international medical journal Nature Medicine on March 19.
More than 330,000 people die from pancreatic cancer worldwide each year, with an overall five-year survival rate of approximately 6 percent, according to the hospital.
By analyzing the data of 191 patients over more than three years of follow-ups, the researchers constructed a prognostic prediction model for pancreatic cancer, and identified two protein markers — NDUFB8 and CEMIP2 — which are able to accurately predict patients' sensitivity to chemotherapy.
Results of the study were independently verified among people with pancreatic cancer in and around Paris, France, and at Fudan University Shanghai Cancer Center and Shanghai Changhai Hospital.
"The research answered one of the two main queries that are current bottlenecks in the field of pancreatic cancer treatment: Which patients are sensitive to chemotherapy and which chemotherapy drugs are they sensitive to?" said Shen Baiyong, a professor at the Pancreatic Disease Diagnosis and Treatment Center of Ruijin Hospital and a leading researcher on the team.
Yvette Fielding says her Most Haunted co
Best stocks & shares Isas: Pick the right investment account
As the Glastonbury 2024 lineup is announced, AI reveals the ultimate headliners
Exquisite suites and unrivalled experiences
Liverpool confirms Arne Slot as Jurgen Klopp's replacement
United Airlines flight is forced to DIVERT after a dog POOPED in first class aisle
Bridges across the US that suffered same fate as Francis Scott Key in Baltimore
Trump accepts a VP debate but wants it on Fox News. Harris has already said yes to CBS
Elon Musk says AI has 'more positives than negatives' as he launches his own anti
Kate Hudson hits the stage to debut songs from her new album Glorious at star
Come fry with me! The UK's cheapest and priciest airports for a full English breakfast revealed